Brentuximab vedotin plus AVD followed by involved-node radiotherapy in a patient with classic Hodgkin lymphoma following gray zone lymphoma after autologous stem-cell transplantation failure.

Ueda, Norihiro; Kato, Harumi; Kato, Seiichi; Saito, Toko; Tachibana, Hiroyuki; Yanada, Masamitsu; Taji, Hirofumi; Kodaira, Takeshi; Hosoda, Waki; Yamamoto, Kazuhito

Ueda, Norihiro; Kato, Harumi; Kato, Seiichi; Saito, Toko; Tachibana, Hiroyuki; Yanada, Masamitsu; Taji, Hirofumi; Kodaira, Takeshi; Hosoda, Waki; Yamamoto, Kazuhito.

Afiliación

Ueda N; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Kato H; Department of Hematology, Komaki City Hospital, Komaki, Japan.
Kato S; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Saito T; Department of Pathology and Molecular Diagnostics, Aichi Cancer Centre Hospital, Nagoya, Japan.
Tachibana H; Center for Clinical Pathology, Fujita Health University hospital, Toyoake, Japan.
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Taji H; Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
Kodaira T; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Hosoda W; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Yamamoto K; Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan.

Hematology ; 28(1): 2207946, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37183912

Asunto(s)

Trasplante de Células Madre Hematopoyéticas; Enfermedad de Hodgkin; Inmunoconjugados; Linfoma de Células B; Humanos; Enfermedad de Hodgkin/patología; Brentuximab Vedotina/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Doxorrubicina; Trasplante Autólogo; Inmunoconjugados/uso terapéutico

Palabras clave

BV+AVD, brentuximab vedotin doxorubicin, vinblastine, and dacarbazin; CHL, classic Hodgkin lymphoma; FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography-computed tomography; GZL, Gray zone lymphoma; Gray zone lymphoma; R-CHOP, rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone; brentuximab vedotin; involved-node radiotherapy; sequential relapse

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Linfoma de Células B / Inmunoconjugados / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hematology Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google